GlassScriptPhysician profile
Barbara L Plucknett
NPI 1518950914
$4,454.72
in general payments reported to CMS, 2019-2025
20 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $152 · 2021: $514 · 2022: $604 · 2023: $526 · 2024: $2,053 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,450 · Travel and Lodging: $1,303 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,450.32 |
| Travel and Lodging | $1,302.50 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,990.31 | 2019-2024 | Da Vinci Surgical System |
| Coloplast Corp | $620.95 | 2019-2025 | |
| Abbvie INC. | $568.06 | 2019-2025 | |
| Astellas Pharma US INC | $341.20 | 2019-2024 | Veozah, Myrbetriq |
| Allergan, INC. | $238.91 | 2019-2022 | |
| Therapeuticsmd, INC. | $152.56 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $131.14 | 2023-2025 | Gemtesa |
| Hologic Sales and Service, LLC | $71.85 | 2022-2023 | Aptima |
| Urovant Sciences INC | $48.41 | 2021 | |
| Pfizer INC. | $48.32 | 2019-2021 | |
| Axonics, INC. | $47.82 | 2022-2023 | Bulkamid |
| Merz North America, INC. | $45.35 | 2023 | |
| Amag Pharmaceuticals, INC. | $29.65 | 2019 | |
| Galderma Laboratories, L.P. | $26.84 | 2025 | |
| Daiichi Sankyo INC. | $21.34 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.21 | 2019 | |
| Minerva Surgical, INC | $17.00 | 2021 | |
| Femselect INC. | $15.13 | 2022 | |
| Amgen INC. | $13.37 | 2022 | |
| Mayne Pharma Commercial LLC | $7.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Plucknett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.